logo

For the Inventor, By the Inventor

North Tonawanda, NY, United States of America

Glenn Godwin

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Life Technologies Corporation. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Glenn Godwin. Retrieved from https://idiyas.com/inventor/glenn-godwin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • North Tonawanda, NY (US) (2012 - 2014)
  • Holbrook, MA (US) (2014 - 2016)

Company Filing History:

goldMedal5 out of 1,892 
 
Life Technologies Corporation
 patents

Years Active: 2012-2016

Loading Chart...
5 patents (USPTO):Explore Patents
1. 9321996 - Serum-free mammalian cell culture medium, and uses thereof (2016-04-26),
2. 8815573 - Serum-free mammalian cell culture medium, and uses thereof (2014-08-26),
3. 8785194 - Serum-free mammalian cell culture medium, and uses thereof (2014-07-22),
4. 8455246 - Serum-free mammalian cell culture medium, and uses thereof (2013-06-04),
5. 8198084 - Serum-free mammalian cell culture medium, and uses thereof (2012-06-12),

Title: Glenn Godwin: Innovator in Cell Culture Technology

Introduction

Glenn Godwin is a notable inventor based in North Tonawanda, NY (US). He has made significant contributions to the field of cell culture technology, particularly in the development of serum-free media for mammalian cells. With a total of 5 patents to his name, Godwin's work has advanced the methods used in biological research and pharmaceutical production.

Latest Patents

One of Glenn Godwin's latest patents is titled "Serum-free mammalian cell culture medium, and uses thereof." This invention provides a cell culture medium formulation that supports the in vitro cultivation of mammalian cells, particularly epithelial and fibroblast cells. The formulation includes a basal medium and a polyanionic compound, such as dextran sulfate, which enhances the growth of these cells in suspension culture. Additionally, the invention offers chemically defined, protein-free eukaryotic cell culture media that contain an iron chelate and zinc, which are essential for high-density growth and increased expression of recombinant proteins in cultured cells. The invention also includes kits designed for the cultivation of mammalian epithelial cells, which contain the specialized culture medium and additional supplements.

Career Highlights

Glenn Godwin has been associated with Life Technologies Corporation, where he has played a pivotal role in advancing cell culture technologies. His innovative approaches have contributed to the development of products that are widely used in research and clinical applications.

Collaborations

Throughout his career, Glenn has collaborated with notable colleagues, including Stephen Gorfien and Richard M. Fike. These collaborations have further enriched his work and expanded the impact of his inventions in the scientific community.

Conclusion

Glenn Godwin's contributions to cell culture technology have made a lasting impact on the field. His innovative patents and collaborations continue to influence research and development in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…